BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2511100)

  • 1. Acute cholestatic Hodgkin's lymphoma: an unusual clinical picture.
    Marinone G; Lazzari R; Pellizzari F; Marinone MG
    Haematologica; 1989; 74(3):293-6. PubMed ID: 2511100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic Hodgkin's disease simulating cholestatic hepatitis with liver failure.
    Lefkowitch JH; Falkow S; Whitlock RT
    Arch Pathol Lab Med; 1985 May; 109(5):424-6. PubMed ID: 3838655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vanishing bile duct syndrome: a possible mechanism for intrahepatic cholestasis in Hodgkin's lymphoma.
    Hubscher SG; Lumley MA; Elias E
    Hepatology; 1993 Jan; 17(1):70-7. PubMed ID: 7678577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Paraneoplastic lymphadenopathy].
    Melikian AL; Nikitin EA; Kaplanskaia IB; Frank GA
    Ter Arkh; 2007; 79(8):44-52. PubMed ID: 17926471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hodgkin's disease presenting as an hepatic disease. Report of two cases (author's transl)].
    Urbano-Márquez A; Grau Junyent JM; Sala M; Estruch R; Bruguera M; Rozman C
    Med Clin (Barc); 1981 Mar; 76(6):255-8. PubMed ID: 7253732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Massive medullary forms of Hodgkin's disease and acute myelofibrosis (author's transl)].
    Duhamel G; Stachowiak J; Monteiro M; Duhamel E
    Nouv Presse Med; 1979 Mar; 8(13):1061-4. PubMed ID: 461133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Spontaneous resolution of vanishing bile duct syndrome in Hodgkin's lymphoma].
    Han WS; Jung ES; Kim YH; Kim CH; Park SC; Lee JY; Chang YJ; Yeon JE; Byun KS; Lee CH
    Korean J Hepatol; 2005 Jun; 11(2):164-8. PubMed ID: 15980675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Paraneoplastic vanishing bile duct syndrome in a case of Hodgkin's disease].
    Allory Y; Métreau J; Zafrani E
    Ann Pathol; 2000 Jan; 20(1):52-5. PubMed ID: 10648987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histology of symptomatic acute hepatitis C infection in immunocompetent adults.
    Johnson K; Kotiesh A; Boitnott JK; Torbenson M
    Am J Surg Pathol; 2007 Nov; 31(11):1754-8. PubMed ID: 18059233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hodgkin's nodular paragranuloma (nodular Hodgkin's disease, with lymphocytic predominance): apropos of 29 cases].
    Molina T; Diebold J
    Bull Cancer; 1987; 74(4):463-72. PubMed ID: 3663967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant histiocytic lymphoma with large lacunar cells.
    Leahu S; Dobrea M
    Rom J Intern Med; 1997; 35(1-4):115-9. PubMed ID: 9562660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The histologic diagnosis of Hodgkin's disease.
    Butler JJ
    Semin Diagn Pathol; 1992 Nov; 9(4):252-6. PubMed ID: 1480847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fascin, a sensitive new marker for Reed-Sternberg cells of hodgkin's disease. Evidence for a dendritic or B cell derivation?
    Pinkus GS; Pinkus JL; Langhoff E; Matsumura F; Yamashiro S; Mosialos G; Said JW
    Am J Pathol; 1997 Feb; 150(2):543-62. PubMed ID: 9033270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic reticulum cell immunoreactivity for low-affinity nerve growth factor receptor in malignant lymphomas.
    Dorfman DM; Shahsafaei A
    Mod Pathol; 1996 Oct; 9(10):959-65. PubMed ID: 8902831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe jaundice, due to vanishing bile duct syndrome, as presenting symptom of Hodgkin's lymphoma, fully reversible after chemotherapy.
    Leeuwenburgh I; Lugtenburg EP; van Buuren HR; Zondervan PE; de Man RA
    Eur J Gastroenterol Hepatol; 2008 Feb; 20(2):145-7. PubMed ID: 18188038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hodgkin's disease following non-Hodgkin's lymphoma. A clinicopathologic and immunophenotypic study of nine cases.
    Zarate-Osorno A; Medeiros LJ; Kingma DW; Longo DL; Jaffe ES
    Am J Surg Pathol; 1993 Feb; 17(2):123-32. PubMed ID: 8422110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How to differentiate between T-cell-rich B-cell lymphoma and lymphocyte-predominant Hodgkin's disease. Evidence for the value of MB1 and 4KB5 immunostaining.
    Schmidt U; Herbst J; Metz KA; Leder LD
    J Pathol; 1996 Jun; 179(2):138-44. PubMed ID: 8758204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Angioblastic lymphadenopathy--its course and prognosis].
    Mihaljević B; Jancić-Nedeljkov R; Janković S; Milivojević G; Cemerikić-Martinović V; Jovanović V; Colović M; Petrović M
    Srp Arh Celok Lek; 1999; 127(11-12):376-82. PubMed ID: 10686819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Angioimmunoblastic lymphadenopathy and Hodgkin's disease].
    Török I; Tiszai A; Boros I; Balázs L; Kelényi G
    Morphol Igazsagugyi Orv Sz; 1981 Apr; 21(2):107-12. PubMed ID: 7266539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hodgkin's disease presenting as cholestatic hepatitis with prominent ductal injury.
    Liangpunsakul S; Kwo P; Koukoulis GK
    Eur J Gastroenterol Hepatol; 2002 Mar; 14(3):323-7. PubMed ID: 11953700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.